This round is no longer accepting investments, but others just like it are live now.

CLOSED

GET A PIECE OF ELEMENO HEALTH

Empower frontline heroes at the point-of-care, in COVID & beyond

Elemeno’s mobile-friendly cloud solution delivers “just-in-time” team training and communication—equipping frontline nurses and doctors to deliver the right care at the right time. On demand, 24/7, at the point-of-care, or anywhere.

This Reg CF offering is made available through StartEngine Capital, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
Company Image

$1,234,241 Raised

TEAM

Arup Roy-Burman, MD

Arup Roy-Burman, MD • Co-Founder & Chief Executive Officer

Dr. Roy-Burman has spent 20 years in ICU leadership at the nation’s top medical centers.

Scott M. Cohen, MHA

Scott M. Cohen, MHA • Chief Operating Officer

Cohen spent 13 years as VP Client Development at athenahealth, from early stage to over $1 Billion in revenue.

Carole A. Klove, RN, JD

Carole A. Klove, RN, JD • Chief Nursing Officer

Former Chief Compliance & Privacy Officer at Stanford and UCLA. Alumni Board of Directors, Duke School of Nursing.



Reasons to Invest


  • Traction & Key Clients: $1 Million ARR. 20+ healthcare facilities. Steady growth through COVID-19. Clients include UCSF Health, El Camino Hospital, Children’s Hospital of New Orleans, RWJBarnabas Health, and Massachusetts General Hospital.
  • Proven ROI & Market Potential: Multiple published results cutting medical errors 50+%. Measured client ROI 10-30x. $2 Billion market.
  • Addresses the biggest problems in healthcare today: medical errors, waste, and burnout.


Overview


Real-Time Point-of-Care Training - Equipping Frontline Teams to Reduce Care Variation, Errors, and Burnout

Elemeno Health is designed by doctors and nurses. We believe in our frontline healthcare workers. We know they want to give the best care possible to every life they touch. Our mission is to equip our heroes with the information and support they need to deliver safe and high quality care to every patient, every time. We enable managers to superpower their teams with custom, point-of-care microlearning and communication, a virtual coach, accessible when, where, and how frontline staff need it most. 

The Problem


Medical Staff Are Overwhelmed, Overworked

Medical errors and burnout— pains we have all seen and heard in every hospital, clinic, and nursing home. And COVID-19 is just making it worse.

Healthcare is becoming increasingly complex. Best practices are rapidly growing and changing. Frontline staff—nurses, docs, and therapists—cannot keep up. They are overwhelmed, yet they are being asked to do more and more. We believe this is resulting to some of the biggest problems in healthcare today:


  • Staffing crisis: We don't have enough frontline staff; healthcare systems need help to RECRUITTRAINSUPPORT, and RETAIN.
  • Medical errors: Inadequately trained/supported staff paired with increasingly complicated practices means increasing CARE VARIATION and ERRORS.
  • Costs: lack of access to best practice standards and inconsistency in frontline practices leads to inefficiencies and waste - and that costs $$$.


Sadly, with these problems healthcare institutions continue to fall back on traditional team training and communication modalities like binders, fliers, email, and in-person staff meetings. These 20th century solutions do not work in 21st century medicine. The result is staff burnout and care variation—meaning medical errors, waste, and job turnover. 

* Source 1, Source 2, Source 3Source 4

The Solution


Transform Complicated Practices Into Bite-Sized Learning

We offer real-time training and support for frontline teams—an expert in your pocket. At Elemeno, we are a software company with a human touch. We provide a dedicated Client Success Manager who ensures ROI and customer satisfaction.

Elemeno’s mobile-friendly cloud solution delivers “just-in-time” team training and communication, equipping frontline nurses and doctors with custom interactive guidelines, smart checklists and concise how-to videos, on-demand, 24/7. 


We make complicated practices actionable, so staff can actually deliver them. Our analytics drive insight into caregiver behavior and practice effectiveness. And our feedback loop gives frontline staff a voice so that management can proactively address frontline needs before they manifest as patient harm. The result is consistent high quality care... 

… meaning greater safety, labor savings, and improved outcomes


You’ve seen the importance of teamwork in healthcare. Healthcare workers want to help each other. Elemeno takes this to the next level. Our sharing network de-silos hospitals, democratizing access to best practices and accelerating knowledge spread across the industry. And we make it easy. No IT needed.

The Market


A Multi-Billion Dollar Market

The US market for clinical staff alone is $2 Billion.

*Source

And here’s how we strategically complement established market channels:

Our Traction


Growth & Proven Results

Here’s how we’ve been doing so far:

How It Works


Create & Deliver

Learn & Do


Healthcare is local! Elemeno is an enterprise solution empowering middle management and frontline teams to address  department-based issues. This is invisible piece of the iceberg ignored by technology to date.




It looks something like this:


The Business Model


How We Make Money

Our revenue system is B2B SaaS with a land and expand model—including an annual subscription and one-time onboarding fee. We start in one department, prove our value, and then work with the happy managers to sell to the rest of the institution.

The Network Effect: Healthcare is all about collaboration! Each department’s content is shared with all others in the same institution, so as each new department joins, everyone has greater benefit. This accelerates our expansions.


The Network Effect 2.0: We take collaboration to the next level. Every client is also able to share practices with managers at peer institutions, so with each new client, our client network has even more to share from. This de-silos hospitals and accelerates the spread and adoption of best practices. Don’t reinvent the wheel. Leverage the collective knowledge of the community. And let inter-client sharing accelerate new client acquisition.

How We Are Different


We Are Pioneers

Healthcare is a constant battle. And nurses, doctors, and ancillaries are our frontline troops. We believe in equipping them for success. Our customized microlearning solution supports our healthcare teams at the point of care, on-demand, 24/7. Our service unites:


  • Efficient and effective team communication—keeping staff up to date with constantly changing information while listening to frontline feedback.

  • In-context microlearning—ensuring sustained top of license best practice.

  • Transparent recognition—supporting teamwork and engagement.

Easy customization allows clients to support their own specific devices, equipment, supplies and protocols, giving frontline staff the exact support they need to succeed in their own unique environment. And, our feedback loop helps managers quantitatively and qualitatively measure frontline needs. We fill the gap left by our competitors.

The Vision


Our Global Vision

In seven years, we want to be an epic business—the go-to network for best practices worldwide.


We aim to democratize access for healthcare workers across the globe, empowering them to become superheroes. This will radically reduce medical errors and enable every clinician to deliver the best care possible to every life they touch.

OUR LEADERSHIP


Meet Elemeno’s Leaders

At Elemeno Health we have a team of strong leaders who have a passion for our mission. We are proud to be certified by the Western Regional Minority Supplier Development Council as a Minority Business (MBE).  We continue to celebrate all diverse backgrounds at Elemeno Health.


Founder and CEO Dr. Arup Roy-Burman and COO Scott Cohen have deep expertise in healthcare delivery,  medical technology, and growing a successful business.

Why Invest


We Are Here to Equip Our Frontline Heroes for Success

Healthcare is moving faster than ever, and our frontline staff cannot keep up. They are overwhelmed, resulting in practice variation and burnout—the root causes of medical errors, waste, and turnover.


Our solution has been developed by doctors and nurses who have felt that pain themselves—using that incentive to fuel a successful product.


We empower our frontline teams with real-time point of care training and support so that they can be superheroes. Our success is demonstrated in our $1M+ ARR traction, proven ROI, and key clients.  And through the sharing network effect, every new client increases value for all clients—a virtuous cycle of collaboration. Come join the movement.

GIF

Quick Insert

ABOUT

HEADQUARTERS
2910 Ford St., Suite D
Oakland, CA 94601
WEBSITE
View Site
Elemeno’s mobile-friendly cloud solution delivers “just-in-time” team training and communication—equipping frontline nurses and doctors to deliver the right care at the right time. On demand, 24/7, at the point-of-care, or anywhere.

TERMS

Elemeno Health
Overview
PRICE PER SHARE
$0.86
DEADLINE
Oct. 23, 2021 at 6:59 AM UTC
VALUATION
$20.03M
FUNDING GOAL
$10K - $3.93M
Breakdown
MIN INVESTMENT
$249.40
MAX INVESTMENT
$106,999.48
MIN NUMBER OF SHARES OFFERED
11,627
MAX NUMBER OF SHARES OFFERED
4,569,766
OFFERING TYPE
Equity
SHARES OFFERED
Series Seed-2 Preferred Stock

Maximum Number of Shares Offered subject to adjustment for bonus shares

We Would Love to Recognize You as a Patient Safety & Nurse Champion.

(Recognitions posted on our Investor web page)

$25,000+ Angel of Nursing

In tribute to Florence Nightingale: The Lady with the Lamp, Visionary Statistician, Founder of Modern Nursing

$10,000+ Red Cross Award

In tribute to Clara Barton: The Lady in Charge, Civil War Nurse, Founder of American Red Cross

$5,000+ Military Nursing Champion

In tribute to Hazel W. Johnson-Brown: Trailblazer in Military Nursing, First Black Chief of the US Army Nurse Corps.

 

$2,200+ Hospice Care Advocate

In tribute to Florence Wald: Mother of Modern Hospice Movement, Advocate for Patients’ Dignity, Freedom from Pain, and Right to make Autonomous Decision

 

$1,000+ Rural Health Ally

In tribute to Mary Breckinridge: Pioneer in Rural healthcare, Founded Frontier Nursing Service, Drastically Decreasing Maternal and Infant Mortality in early 1900’s

 

$300+ Public Health Contributor

In tribute Lillian Wald: Pioneer in Public Health, American Nurse, Humanitarian

 

(Here's how prior investors from Republic are honored on our web page: https://www.elemenohealth.com/investors/)

Irregular Use of Proceeds

We will not incur any irregular use of proceeds.

ALL UPDATES

11.05.24

2024 Public Benefit Corporation Report

2024 Public Benefit Corporation Report

Elemeno Health is a Delaware Public Benefit Corporation. The specific public benefit purpose of the Corporation is to democratize frontline access to best practices and enable healthcare institutions to deliver safer care at a lower cost.

Our Objectives

  • Launch Elemeno in distinct healthcare facilities

  • Support team leaders to advance team priorities

  • Empower frontline healthcare professionals with just-in-time resources

  • Promote knowledge and best practice resource sharing between healthcare facilities

Our Standards/Metrics

  • Number of sites/facilities

  • Number of individual teams (units or departments)

  • Number of annual active users

  • Number of knowledge and best practice resources available to frontline workers

  • Number of knowledge and best practice resources available in our shared library

Our Performance (Oct 2024)

  • Number of sites/facilities: 38 instances of our app serving 42 hospitals, many with additional facility/campus/clinic locations

  • Number of individual teams (units or departments) supported: >300

  • Number of annual active users: >10,000

  • Number of knowledge and best practice resources available to frontline workers: >17,800

  • Number of knowledge and best practice resources available in our shared library: >2,600

Our Impact

Elemeno delivers just-in-time support to frontline healthcare professionals so that they can consistently provide higher quality care. Consistency with desired processes improves outcomes, which are measured by our clients. Our clients are repeatedly presenting and publishing results highlighting their successful use of Elemeno to improve quality and lower costs.

  • Decreased staff onboarding/orientation times (40-60%)

  • Reduced training costs (by up to $14,000/RN)

  • Improved patient outcomes (decreasing hospital-acquired conditions by up to 75%)

Our continued growth and expansion of the use of Elemeno to more facilities, more teams, and more healthcare professionals is expanding the delivery of high quality, equitable care to the general public and improving the financial sustainability of healthcare institutions.



08.19.22

Elemeno Health Q2 2022 Update

Dear Elemeno Health Investors,

In this year of global market volatility and a seemingly endless pandemic, I am pleased to announce closing of our $7M Series A financing, led by SJF Ventures! SJF has been a leader in both venture capital and sustainability for over 20 years. They are currently investing out of their fifth fund ($150M) and led our round with a $5M investment. SJF was joined by Sustain VC, which invested an additional $1M alongside.

Omicron has hit health systems hard—not only with another surge of patients, but more importantly this time, with staff. As so many frontline caregivers became ill and/or left their positions, management were—and continue to be—pulled into staffing. This translated to near halting of the follow up internal multi-stakeholder meetings at prospects necessary to close new deals. With so many staff out—across clinical care, leadership, IT, and training—it has been especially challenging to drive necessary group approvals in a timely manner. Although this has flattened sales, the underlying pain for health systems (high workforce turnover paired with growing healthcare complexity) is more acute than ever.

SJF Ventures saw the opportunity. They dove into our business over 5 months, including deep diligence with many of our customers. With strong domain expertise in both healthcare and workforce development, SJF was excited to welcome their first portfolio company crossing these two critically important verticals. This is how SJF recently described their investment:

“SJF Ventures led the $7 million Series A investment round in Elemeno Health, the developer of a proprietary solution serving frontline healthcare teams. Elemeno has built a “playbook in your pocket” for nurses, which helps them enhance patient care and execute their day-to-day tasks more efficiently. The “playbook” includes easily digestible content that can be customized by individual hospital departments. Its use has been associated with increased nurse satisfaction and a decrease in turnover by up to 50%. Improved consistency of care has resulted in decreased medical errors and hospital-acquired conditions by up to 75%.”

Read more about SJF's investment in Elemeno here

Now with the steady return of in-person conferences, combined with increasing word of mouth, we are seeing good growth in new leads to add to our pipeline. And with the Series A, we are deploying capital to service our growing demand.

KPIs:

  • Q2 Annual Recurring Revenue (ARR): $1.76M (incremental growth v Q1) 
  • Churn: 0
  • New business: $15k (expansion)
  • Q2 Pipeline: $5.42M (increased from $4.17M Q1)

Sales:

  • New logos/contracts: None in Q2 (our next sale, first in NY state, will be closed/launched in August)
  • Expansions: One hospital system
  • Pipeline Total: $5.42M (direct sales)
    • Qualification/Discovery: $1.75M ($263k estimated close)
    • Solution Design: $1.28M ($384k est. close)
    • Proposal: $2.27M ($1.36M est. close)
    • Negotiation: $113K ($101k est. close)
  • Team:
    • We are thrilled to announce the arrival of Amy Waldrup PhD, MSN, RN, as our first Key Accounts Executive. Amy is former Sr. Director of Patient Care Services at Children’s New Orleans, one of our long time enterprise clients. Amy will be focused on building relationships with our executive sponsors and accelerating client expansions.
    • We have been pleased to have so many nurses joining Elemeno, as they have deep empathy for the pains of our customers. We have recently transitioned one of our RN Client Success leads to sales, and we are in negotiation for a Head of Sales with deep experience in hospital sales, sales mechanics, and startup/growth success. Stay tuned!
    • In the interim, we have been building out sales process automation, allowing us to standardize sales motions across all team members and ensure fidelity of practice.

Marketing:

  • Building the Messaging Foundation
    • Quantitative Market Research: We are contracting with an outside party to conduct qualitative market research so that we clearly understand which messages resonate with our target audience (s). The insights gleaned from this project will make it easier to create impactful marketing materials that resonate with our audience (Chief Nursing Officers, unit/dept directors, etc.)
  • Collateral Development
    • Case studies: together with our clients, we are writing up multiple case studies with current clients who have shown $100k+ savings in training costs, 20+% reduction in orientation hours, and improved patient outcomes
    • Product Marketing Toolkit: describes what we do, how we do it and how we do it better.  Emphasis on our Client Success team offloading work from our dept champions.
    • FAQ for Sales: internal document to ensure consistent messaging across our growing team
  • Upcoming Conferences in Q3/4 (Elemeno exhibiting)

Press:

Product & Engineering:

  • Client Success welcomes Tammy Franquiero RN, MSN as our Exec Director of Client Success. Tammy is the former VP of Client Success at Versant Healthcare Competency Solutions, which focuses on training of new nurses.
  • Content welcomes Tiffany Goralczyk RN, MSN as our Manager of Content Production. Tiffany previously served in Nurse Education leadership at Rush University Medical Center and will be honored next month by the Illinois Nurses Foundation as one of the 2022 Top 40 Emerging Nurse Leaders Under 40.
  • Engineering welcomes two new engineers.
  • Current Product development workstreams include User Experience research and design upgrade, and content management and reporting tools.

Finance:

  • Series A closed with $7M
  • Runway based on current sales projection: lowest point in Q4 2023
  • While in a good cash position, the global healthcare economic outlook continues to be volatile. With deploying capital now, we are simultaneously working together with our Board to proactively prioritize options to ensure long term fiscal security.

 Market valuations go up and down, and opportunities ebb and flow. We thank all of our early investors for getting us to where we are now. And we thank our new investors for backing us in turbulent times, so that we all have the potential to realize our vision for the future.

Best,

Arup

 

12.13.21

WE DID IT! Elemeno Wins 2021 Emergency Medicine Innovation of the Year!

Hey StartEngine Team! You helped make the difference!


The American College of Emergency Physicians has named Elemeno Health 2021 Emergency Medicine Innovation of the Year! The pandemic has underscored how fast healthcare is moving, and the dire need for a quick and easy solution to keep frontline teams on top of constantly changing information, localized to your own hospital and teams. Elemeno fills the gap with a "playbook in your pocket," readily customized to your department's needs. And, Elemeno's cloud exchange is helping hospitals around the country share practices with each other. Let's democratize access to best practices, and empower every healthcare professional to deliver the right practice to the right patient at the right time!

Thanks for your support!

10.23.21

WE NEED YOUR HELP: Please Vote NOW for Elemeno for Emergency Medicine Innovation of the Year

Elemeno Investors and Followers,

Elemeno has been selected one of four finalists for Emergency Medicine Innovation of the Year by the American College of Emergency Physicians. Voting just started-- and the public can vote!!!

Please vote ASAP for us-- and please share the link with your network.

Let's go Elemeno!

https://woobox.com/biaesx

10.15.21

Elemeno Health Q3 Update: StartEngine Campaign Closing 10/22

We’ve had a great Q3, with growth in sales and leads in the face of the delta surge. Delta has hit many of our clients and prospects hard, especially those in the South. Hospitals in the affected areas are suffering from staff shortages, high costs of traveler nurses, and rapidly increasing burnout. This makes it challenging to get their attention. Nonetheless, we are rising above the noise, and they are seeing the value of Elemeno. We have closed new deals in these regions, and we have successfully launched two new partnerships. We have closed over $1M in new investments, and we have  institutional investors (traditional VC and strategics) interested in additional investment.

KPIs:

  • Annual Recurring Revenue (ARR) $1.35M

  • Churn: 0

  • Pipeline: $4.8M

  • Channel Partners: 2

Highlights:

  • New logos/contracts:

    • 3 new Louisiana clients: Touro Infirmary, East Jefferson Hospital, West Jefferson Hospital

    • 1st Southern California client launched: Pacific Neurosciences Institute

    • Benioff Children’s Hospital San Francisco converted from free to paying client

  • Expansions:

    • Expanded from Inpatient to Ambulatory: Children’s Hospital Oakland

    • From Inpatient to external/referring providers: UCSF

    • From single hospital to system: LCMC Health

  • Channel Partnerships:

    • National Perinatal Information Center launched: first jointly developed lead now in contracting

    • Texas Hospital Association launched: initial marketing pitch narrowed to help onboard traveler nurses and new hires; already presenting to new leads

  • We launched our new website! Check it out: https://www.elemenohealth.com/. We can now track visitors in greater detail, helping us determine from where visitors are coming and what they are looking for. This informs our marketing and drives strategic spend to grow our leads

  • In the News:

    • Television: Healthcare institutions are struggling to keep staff up to date with rapidly changing information. When staff are secure, confident, and resilient, they stay with their job, and their patients receive better care. ABC news in SF recently highlighted Elemeno's role, here

    • Newspaper: Elemeno founder story featured in India West, here

    • Video Podcast: Elemeno story featured on KingsCrowd podcast, youtube

    • Video: Nursing Innovation HUB CEO Interviews Elemeno Nurse User and Investor, vimeo

    • Audio Podcast: Elemeno founder interview with Angel Notes, here

Finance:

  • We are thrilled to have raised over $1M on StartEngine and will be closing the campaign on 10/22

  • We plan to raise the balance of our immediate needs from institutional investors

10.07.21

Elemeno Health and Texas Hospital Association Announce Partnership to Aid Frontline Health Care Staff in Texas


Sharing the launch of our partnership with the Texas Hospital Association, where we are jointly offering member hospitals the Elemeno solution to support their frontline staff, especially in the context of onboarding travelers and new grads. Press release here.


Fernando Martinez, Ph.D., president of the THA Foundation: "Elemeno Heath’s microlearning platform provides a solution to the challenge of keeping clinical staff educated and up-to-date on procedures and hospital-specific best practices."


THA has started reaching to members, and we already have interested leaders!

10.04.21

Notice of Funds Disbursement

[The following is an automated notice from the StartEngine team].

Hello!

As you might know, Elemeno Health has exceeded its minimum funding goal. When a company reaches its minimum on StartEngine, it's about to begin withdrawing funds. If you invested in Elemeno Health be on the lookout for an email that describes more about the disbursement process.


This campaign will continue to accept investments until its indicated closing date.


Thanks for funding the future.

-StartEngine

09.22.21

Elemeno Launches New Website!

Hey All!

Check out our new website, with messaging and analytics optimized for lead generation and sales!


And here, share with your friends and colleagues our landing page for crowd investors: https://elemenohealth.com/startengine/

Let's get this out on your social media channels! Bring more of the crowd on! Working together we can empower our frontline teams and make healthcare work the way it should!

09.17.21

Elemeno Health Rated "Deal to Watch" By KingsCrowd, the #1 Equity Crowdfunding Startup Data & Analytics Platform

Elemeno Health is currently rated a 4.6/5 by KingsCrowd’s proprietary Merlin startup rating algorithm. This high score places Elemeno among the elite equity crowdfunding campaigns currently available for investment.

KingsCrowd independently vets and analyzes startups across the entire online crowdfunding market and is used by more than 100,000 investors.

Interested parties can obtain a free digital copy of  KingsCrowd’s full Elemeno Health Rating & Analysis Report. 

Highlights include:

  • Why Elemeno Health has been ranked a Deal to Watch
  • Both the Bull and Bear Cases of investing compiled by KingsCrowd's industry-leading analyst team. 
  • A comprehensive deep-dive into Elemeno Health's growth plans, management team, and KingsCrowd's proprietary Merlin Rating. 

Click here to read KingsCrowd’s Elemeno Health Rating & Analysis Report.

Elemeno did not solicit nor in any way compensate KingsCrowd for this analysis.

09.16.21

Notice of Funds Disbursement

[The following is an automated notice from the StartEngine team].

Hello!

As you might know, Elemeno Health has exceeded its minimum funding goal. When a company reaches its minimum on StartEngine, it's about to begin withdrawing funds. If you invested in Elemeno Health be on the lookout for an email that describes more about the disbursement process.


This campaign will continue to accept investments until its indicated closing date.


Thanks for funding the future.

-StartEngine

REWARDS

Multiple investments in an offering cannot be combined to qualify for a larger campaign reward.

$300

Public Health Contributor

In tribute Lillian Wald: Pioneer in Public Health, American Nurse, Humanitarian

$1,000

Rural Health Ally

In tribute to Mary Breckinridge: Pioneer in Rural healthcare, Founded Frontier Nursing Service, Drastically Decreasing Maternal and Infant Mortality in early 1900’s

$2,200

Hospice Care Advocate

In tribute to Florence Wald: Mother of Modern Hospice Movement, Advocate for Patients’ Dignity, Freedom from Pain, and Right to make Autonomous Decision

$5,000

Military Nursing Champion

In tribute to Hazel W. Johnson-Brown: Trailblazer in Military Nursing, First Black Chief of the US Army Nurse Corps.

$10,000

Red Cross Award

In tribute to Clara Barton: The Lady in Charge, Civil War Nurse, Founder of American Red Cross

$25,000

Angel of Nursing

In tribute to Florence Nightingale: The Lady with the Lamp, Visionary Statistician, Founder of Modern Nursing

JOIN THE DISCUSSION

0/2500

PINNED BY STARTUP

LC
Lucinda Collinson

4 years ago

I am a nurse educator at UCSF. I love Elemeno. Elemeno has helped me increase my effectiveness and efficiency, and helped my nursing staff save time and improve patient outcomes. Through Elemeno we have been able to help other hospitals, too. Elemeno is a game changer. I invested in Elemeno last year on Republic. It was awesome to see so many caregivers join in then. I'm a believer and am investing again in this round on Start Engine.

Show more

1

2

PINNED BY STARTUP

DL
David Laquidara

4 years ago

As a nurse and as an end user I can say this is a great product. Easy to use and much better than searching through emails / binders trying to find our latest updates.

Show more

1

1

AP
Alpesh Parmar

6 months ago

Can we get an update on this investment? Elemeno is raising capital now on Wefunder at $5M valuation so does that mean we have lost money after being invested in this for four years. We invested at $20M valuation and $0.86/share. Share price on Wefunder is showing as $0.04/share.

Show more

0

0

JB
James Bondulich

2 years ago

Was another $6MM worth of shares sold in the 22 March SEC filing? Is there any plans to inform the small investors what is going on with the company. The quarterly updates used to be nice, but it has been a few quarters since I've seen one.

Show more

1

0

AK
Andras Konya

3 years ago

Thanks for the thorough Q2 update. Can you say what the new share price/valuation is?

4

0

WT
William Tisdale

3 years ago

Hi, could you update us with the valuation and share price of the series A raise? Thanks!

0

0

VJ
Vaibhav Jain

3 years ago

Hi Arup, Elemeno health team and the community. Congratulations for the $7M series A raise to Elemeno. With this raise, we investors would love to see the updated value of our shareholding. How and when would we be able to see that? Also would there be other opportunities for existing investors to reinvent? Thanks VJ Medtech Entrepreneur

Show more

2

0

JB
James Bondulich

3 years ago

Hello Arup, I hope things are well. Towards the bottom of the Jan. 2022 update, you mentioned that we are looking for a Reg A offering via "Traditional VCs" by the end of Q1. Do you have any update on that and how things are going in general so far this years?

Show more

0

0

CM
CLAIRE MCCANN

4 years ago

In the process of investing, but was given pause when I saw a 70% Approval Rating on Owler for the founder. And 2.2% on Glassdoor, with this as one of the reviews, which is quite concerning: Cons: "C-Suite is focused on micromanaging the minutia (editing PowerPoints, interviewing interns, etc.) instead of creating business plans and leadership. They are unable to prioritize or focus on the big picture, and instead emotionally invest in initiatives that have poor ROI. For a company with less than 20 employees, it is extremely siloed and there are a lot of mixed messages. For example, I would be given an assignment and then find out that the CEO and COO started working on their own version, causing a lot of confusion and wasted effort. When things go poorly, leadership talks about staff behind their back, scapegoat, gaslight, and then fire people. The mission and values on the website are not reflected in the culture. I was never set up for success. Advice to Management: Hire the right people and get out of their way. Stop micromanaging and focus on the big picture. Enroll leadership in sexual harassment and anti-bullying training."

Show more

2

0

JB
James Bondulich

4 years ago

Now that this funding round has closed, what is next?

1

0

HOW INVESTING WORKS

Cancel anytime before 48 hours before a rolling close or the offering end date.

FAQ Timeline

WHY STARTENGINE?

Rewards Icon
REWARDS

We want you to succeed and get the most out of your money by offering rewards and memberships!

Lock Icon
SECURE

Your info is your info. We take pride in keeping it that way!

Ellipse Icon
DIVERSE INVESTMENTS

Invest in over 200 start-ups and collectibles!

FAQS

With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors.

With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000 are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, they are limited to investing 10% of the greater of the two amounts.

At the close of an offering, all investors whose funds have “cleared” by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward.

Please keep in mind that a company can conduct a series of “closes” or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.

StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.

For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as ‘Invested’ on your account dashboard, your investment can no longer be canceled.

For Regulation A+, StartEngine allows for a four-hour cancellation period. Once the four-hour window has passed, it is up to each company to set their own cancellation policy. You may find the company’s cancellation policy in the company’s offering circular.

Once your investment is canceled, there is a 10-day clearing period (from the date your investment was submitted). After your funds have cleared the bank, you will receive your refund within 10 business days.

Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to be sent back to the account associated with the investment.

Both Title III (Regulation Crowdfunding) and Title IV (Reg A+) help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, click here, and for Regulation A+, click here.

PREVIOUSLY CROWDFUNDED
$1,070,000
RAISED
$1,234,241
INVESTORS
327
MIN INVEST
$249.40
VALUATION
$20.03M

Important Message

IN MAKING AN INVESTMENT DECISION, INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. INVESTMENTS ON STARTENGINE ARE SPECULATIVE, ILLIQUID, AND INVOLVE A HIGH DEGREE OF RISK, INCLUDING THE POSSIBLE LOSS OF YOUR ENTIRE INVESTMENT.

www.StartEngine.com is a website owned and operated by StartEngine Crowdfunding, Inc. (“StartEngine”), which is neither a registered broker-dealer, investment advisor nor funding portal.

Unless indicated otherwise with respect to a particular issuer, all securities-related activity is conducted by regulated affiliates of StartEngine: StartEngine Capital LLC, a funding portal registered here with the US Securities and Exchange Commission (SEC) and here as a member of the Financial Industry Regulatory Authority (FINRA), or StartEngine Primary LLC (“SE Primary”), a broker-dealer registered with the SEC and FINRA / SIPC. You can review the background of our broker-dealer and our investment professionals on FINRA’s BrokerCheck here. StartEngine Secondary is an alternative trading system (ATS) regulated by the SEC and operated by SE Primary. SE Primary is a member of SIPC and explanatory brochures are available upon request by contacting SIPC at (202) 371-8300.

StartEngine facilitates three types of primary offerings:

1) Regulation A offerings (JOBS Act Title IV; known as Regulation A+), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Primary, LLC (unless otherwise indicated). 2) Regulation D offerings (Rule 506(c)), which are offered only to accredited investors. These offerings are made through StartEngine Primary, LLC. 3) Regulation Crowdfunding offerings (JOBS Act Title III), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Capital, LLC. Some of these offerings are open to the general public, however there are important differences and risks.

Any securities offered on this website have not been recommended or approved by any federal or state securities commission or regulatory authority. StartEngine and its affiliates do not provide any investment advice or recommendation and do not provide any legal or tax advice concerning any securities. All securities listed on this site are being offered by, and all information included on this site is the responsibility of, the applicable issuer of such securities. StartEngine does not verify the adequacy, accuracy, or completeness of any information. Neither StartEngine nor any of its officers, directors, agents, and employees makes any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy, or completeness of any information on this site or the use of information on this site.

Investing in private company securities is not suitable for all investors. An investment in private company securities is highly speculative and involves a high degree of risk. It should only be considered a long-term investment. You must be prepared to withstand a total loss of your investment. Private company securities are also highly illiquid, and there is no guarantee that a market will develop for such securities. Each investment also carries its own specific risks, and you should complete your own independent due diligence regarding the investment. This includes obtaining additional information about the company, opinions, financial projections, and legal or other investment advice. Accordingly, investing in private company securities is appropriate only for those investors who can tolerate a high degree of risk and do not require a liquid investment. See additional general disclosures here.

By accessing this site and any pages on this site, you agree to be bound by our Terms of use and Privacy Policy, as may be amended from time to time without notice or liability.

Canadian Investors

Investment opportunities posted and accessible through the site will not be offered to Canadian resident investors. Potential investors are strongly advised to consult their legal, tax and financial advisors before investing. The securities offered on this site are not offered in jurisdictions where public solicitation for offerings is not permitted; it is solely your responsibility to comply with the laws and regulations of your country of residence.

California Investors Only – Do Not Sell My Personal Information (800-317-2200). StartEngine does not sell personal information. For all customer inquiries, please write to contact@startengine.com.

StartEngine Marketplace (“SE Marketplace”) is a website operated by StartEngine Primary, LLC (“SE Primary”), a broker-dealer that is registered with the SEC and a member of FINRA and the SIPC.

StartEngine Secondary (“SE Secondary”) is our investor trading platform. SE Secondary is an SEC-registered Alternative Trading System (“ATS”) operated by SE Primary that matches orders for buyers and sellers of securities. It allows investors to trade shares purchased through Regulation A+, Regulation Crowdfunding, or Regulation D for companies who have engaged StartEngine Secure LLC as their transfer agent. The term “Rapid,” when used in relation to transactions on SE Marketplace, specifically refers to transactions that are facilitated on SE Secondary, This is because, unlike with trades on the StartEngine Bulletin Board (“SE BB”), trades on SE Secondary are executed the moment that they are matched.

StartEngine Bulletin Board (“SE BB”) is a bulletin board platform on which users can indicate to each other their interest to buy or sell shares of private companies that previously executed Reg CF or Reg A offerings not necessarily through SE Primary. As a bulletin board platform, SE BB provides a venue for investors to access information about such private company offerings and connect with potential sellers. All investment opportunities on SE BB are based on indicated interest from sellers and will need to be confirmed. Even if parties express mutual interest to enter into a trade on SE BB, a trade will not immediately result because execution is subject to additional contingencies, including among others, effecting of the transfer of the shares from the potential seller to the potential buyer by the issuer and/or transfer agent. SE BB is distinct and separate from SE Secondary. SE Secondary facilitates the trading of securities by matching orders between buyers and sellers and facilitating executions of trades on the platform. By contrast, under SE BB, SE Primary assists with the facilitation of a potential resulting trade off platform including, by among other things, approaching the issuer and other necessary parties in relation to the potential transaction. The term “Extended”, when used in relation to transactions on SE Marketplace denotes that these transactions are conducted via SE BB, and that these transactions may involve longer processing times compared to SE Secondary for the above-stated reasons.

Even if a security is qualified to be displayed on SE Marketplace, there is no guarantee an active trading market for the securities will ever develop, or if developed, be maintained. You should assume that you may not be able to liquidate your investment for some time or be able to pledge these shares as collateral.

The availability of company information does not indicate that the company has endorsed, supports, or otherwise participates with StartEngine. It also does not constitute an endorsement, solicitation or recommendation by StartEngine. StartEngine does not (1) make any recommendations or otherwise advise on the merits or advisability of a particular investment or transaction, (2) assist in the determination of the fair value of any security or investment, or (3) provide legal, tax, or transactional advisory services.